Other Assets, Current in USD of BIOMARIN PHARMACEUTICAL INC from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
BIOMARIN PHARMACEUTICAL INC quarterly Other Assets, Current history and change rate from Q2 2010 to Q3 2025.
  • BIOMARIN PHARMACEUTICAL INC Other Assets, Current for the quarter ending 30 Sep 2025 was $204,265,000, a 21% increase year-over-year.
Source SEC data
View on sec.gov
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Change (%)

BIOMARIN PHARMACEUTICAL INC Quarterly Other Assets, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $204,265,000 +$35,005,000 +21% 30 Sep 2025 10-Q 28 Oct 2025 2025 Q3
Q2 2025 $177,183,000 +$16,757,000 +10% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $181,545,000 +$18,258,000 +11% 31 Mar 2025 10-Q 02 May 2025 2025 Q1
Q4 2024 $201,533,000 +$60,142,000 +43% 31 Dec 2024 10-Q 28 Oct 2025 2025 Q3
Q3 2024 $169,260,000 -$55,546,000 -25% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $160,426,000 -$32,965,000 -17% 30 Jun 2024 10-Q 05 Aug 2024 2024 Q2
Q1 2024 $163,287,000 -$9,893,000 -5.7% 31 Mar 2024 10-Q 26 Apr 2024 2024 Q1
Q4 2023 $141,391,000 +$36,870,000 +35% 31 Dec 2023 10-K 24 Feb 2025 2024 FY
Q3 2023 $224,806,000 +$74,955,000 +50% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $193,391,000 +$54,362,000 +39% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 $173,180,000 +$51,897,000 +43% 31 Mar 2023 10-Q 28 Apr 2023 2023 Q1
Q4 2022 $104,521,000 -$5,921,000 -5.4% 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q3 2022 $149,851,000 +$42,100,000 +39% 30 Sep 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 $139,029,000 +$39,983,000 +40% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $121,283,000 +$30,034,000 +33% 31 Mar 2022 10-Q 29 Apr 2022 2022 Q1
Q4 2021 $110,442,000 -$19,492,000 -15% 31 Dec 2021 10-K 27 Feb 2023 2022 FY
Q3 2021 $107,751,000 -$12,996,000 -11% 30 Sep 2021 10-Q 29 Oct 2021 2021 Q3
Q2 2021 $99,046,000 -$43,081,000 -30% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $91,249,000 -$64,568,000 -41% 31 Mar 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 $129,934,000 -$723,000 -0.55% 31 Dec 2020 10-K 25 Feb 2022 2021 FY
Q3 2020 $120,747,000 -$5,801,000 -4.6% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $142,127,000 +$22,348,000 +19% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $155,817,000 +$61,941,000 +66% 31 Mar 2020 10-Q 01 May 2020 2020 Q1
Q4 2019 $130,657,000 +$32,254,000 +33% 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q3 2019 $126,548,000 +$54,896,000 +77% 30 Sep 2019 10-Q/A 04 Nov 2019 2019 Q3
Q2 2019 $119,779,000 +$39,707,000 +50% 30 Jun 2019 10-Q 02 Aug 2019 2019 Q2
Q1 2019 $93,876,000 +$22,116,000 +31% 31 Mar 2019 10-Q 29 Apr 2019 2019 Q1
Q4 2018 $98,403,000 +$24,367,000 +33% 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q3 2018 $71,652,000 -$11,994,000 -14% 30 Sep 2018 10-Q 26 Oct 2018 2018 Q3
Q2 2018 $80,072,000 +$17,197,000 +27% 30 Jun 2018 10-Q 03 Aug 2018 2018 Q2
Q1 2018 $71,760,000 +$11,420,000 +19% 31 Mar 2018 10-Q 27 Apr 2018 2018 Q1
Q4 2017 $74,036,000 +$12,328,000 +20% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q3 2017 $83,646,000 +$15,237,000 +22% 30 Sep 2017 10-Q 31 Oct 2017 2017 Q3
Q2 2017 $62,875,000 +$930,000 +1.5% 30 Jun 2017 10-Q 02 Aug 2017 2017 Q2
Q1 2017 $60,340,000 +$2,133,000 +3.7% 31 Mar 2017 10-Q 04 May 2017 2017 Q1
Q4 2016 $61,708,000 +$1,330,000 +2.2% 31 Dec 2016 10-K 26 Feb 2018 2017 FY
Q3 2016 $68,409,000 -$46,921,000 -41% 30 Sep 2016 10-Q 03 Nov 2016 2016 Q3
Q2 2016 $61,945,000 -$15,613,000 -20% 30 Jun 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 $58,207,000 -$26,058,000 -31% 31 Mar 2016 10-Q 02 May 2016 2016 Q1
Q4 2015 $60,378,000 -$48,146,000 -44% 31 Dec 2015 10-K 27 Feb 2017 2016 FY
Q3 2015 $115,330,000 +$58,872,000 +104% 30 Sep 2015 10-Q 02 Nov 2015 2015 Q3
Q2 2015 $77,558,000 +$40,290,000 +108% 30 Jun 2015 10-Q 05 Aug 2015 2015 Q2
Q1 2015 $84,265,000 +$43,252,000 +105% 31 Mar 2015 10-Q 05 May 2015 2015 Q1
Q4 2014 $108,524,000 +$66,817,000 +160% 31 Dec 2014 10-K 29 Feb 2016 2015 FY
Q3 2014 $56,458,000 +$28,297,000 +100% 30 Sep 2014 10-Q 28 Oct 2014 2014 Q3
Q2 2014 $37,268,000 +$3,742,000 +11% 30 Jun 2014 10-Q 31 Jul 2014 2014 Q2
Q1 2014 $41,013,000 +$5,512,000 +16% 31 Mar 2014 10-Q 02 May 2014 2014 Q1
Q4 2013 $41,707,000 +$16,198,000 +63% 31 Dec 2013 10-K 02 Mar 2015 2014 FY
Q3 2013 $28,161,000 -$26,655,000 -49% 30 Sep 2013 10-Q 28 Oct 2013 2013 Q3
Q2 2013 $33,526,000 -$24,547,000 -42% 30 Jun 2013 10-Q 29 Jul 2013 2013 Q2
Q1 2013 $35,501,000 -$15,018,000 -30% 31 Mar 2013 10-Q 29 Apr 2013 2013 Q1
Q4 2012 $25,509,000 +$6,871,000 +37% 31 Dec 2012 10-K 26 Feb 2014 2013 FY
Q3 2012 $54,816,000 +$14,851,000 +37% 30 Sep 2012 10-Q 29 Oct 2012 2012 Q3
Q2 2012 $58,073,000 +$21,787,000 +60% 30 Jun 2012 10-Q 02 Aug 2012 2012 Q2
Q1 2012 $50,519,000 +$15,535,000 +44% 31 Mar 2012 10-Q 30 Apr 2012 2012 Q1
Q4 2011 $18,638,000 -$15,236,000 -45% 31 Dec 2011 10-K 26 Feb 2013 2012 FY
Q3 2011 $39,965,000 +$8,218,000 +26% 30 Sep 2011 10-Q 31 Oct 2011 2011 Q3
Q2 2011 $36,286,000 +$13,511,000 +59% 30 Jun 2011 10-Q 01 Aug 2011 2011 Q2
Q1 2011 $34,984,000 31 Mar 2011 10-Q 29 Apr 2011 2011 Q1
Q4 2010 $33,874,000 31 Dec 2010 10-K 22 Feb 2012 2011 FY
Q3 2010 $31,747,000 30 Sep 2010 10-Q 29 Oct 2010 2010 Q3
Q2 2010 $22,775,000 30 Jun 2010 10-Q 04 Aug 2010 2010 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.